CGT, Medical Device and Ocular Safety Assessment Services

Pharmaron’s special safety assessment services cover CGT, ocular, and medical device products. These three types of medical modalities are unique in terms of in-life techniques, bioanalytical methodologies, and regulatory requirements compared to other test articles.

Over the years, Pharmaron has established comprehensive, end-to-end safety assessment platforms tailored to address the unique needs of CGT, ocular, and medical device products. The teams have an excellent track record in delivering high-quality studies to support regulatory submissions to FDA, EMA, and NMPA. For other general safety assessment services, please click here.